Hughes ZA

Gilgamesh Pharmaceuticals, New York, NY, USA.

3 papers · ORCID

ArticlePsilocybin

An exploration of the relationships between the effects of psilocybin on behavior, 5-HT<sub>2A</sub> receptor occupancy, and neuroplastic effects in mice.

Maltby CJ, Klein AK, Paschen E +6

Europe PMC2026
ArticlePsilocybin

A novel psychedelic 5-HT<sub>2A</sub> receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer.

Marek GJ, Makai-Bölöni S, Umbricht D +16

Europe PMC2026
ArticlePsilocybin

Low (micro)doses of 2,5-dimethoxy-4-propylamphetamine (DOPR) increase effortful motivation in low-performing mice.

Noback M, Kenton JA, Klein AK +5

Europe PMC2025